Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: Clues for diagnosis

Laboratory Investigation

Volumn 93, Issue 12, 2013, Pages 1331-1338

  Yamazaki, Hiroshi ^a   Mori, Taisuke ^b   Yazawa, Masaki ^c   Maeshima, Akiko M ^b   Matsumoto, Fumihiko ^b   Yoshimoto, Seiichi ^b   Ota, Yoshihide ^a   Kaneko, Akihiro ^a   Tsuda, Hitoshi ^b   Kanai, Yae ^b  

^a TOKAI UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bmi1; head and neck; HMGA2; squamous cell carcinoma

Indexed keywords

ARF PROTEIN; BMI1 PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HIGH MOBILITY GROUP A2 PROTEIN; BMI1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER STEM CELL; CANCER TISSUE; CARCINOMA CELL; CELL RENEWAL; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; CARCINOMA, SQUAMOUS CELL; DNA MICROARRAY; GENE EXPRESSION PROFILING; METABOLISM; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HMGA2 PROTEIN; HUMANS; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYCOMB REPRESSIVE COMPLEX 1; TUMOR MARKERS, BIOLOGICAL;

EID: 84888329046     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.120     Document Type: Article

References (32)

1. Termine N, Panzarella V, Falaschini S, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008;19:1681-1690.
2. Shackleton M, Quintana E, Fearon ER, et al. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009;138:822-829.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988.
4. Joshua B, Kaplan MJ, Doweck I, et al. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness. Head Neck 2012;34:42-49.
5. Zhang Z, Filho MS, Nor JE. The biology of head and neck cancer stem cells. Oral Oncol 2011;48:1-9.
6. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
7. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
8. Umezawa A, Gorham JD. Dueling models in head and neck tumor formation. Lab Invest 2010;11:1546-1548.
9. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;3:895-902.
10. Mori T, Kiyono T, Imabayashi H, et al. Combination of hTERT and bmi- 1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol 2005;25:5183-5195.
11. Effendi K, Mori T, Komuta M, et al. Bmi-1 gene is upregulated in earlystage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression. Cancer Sci 2010;101:666-672.
12. Ohtomo R, Mori T, Shibata S, et al. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod Pathol 2013;26: 1041-1050.
13. Chaves-Perez A, Mack B, Maetzel D, et al. EpCAM regulates cell cycle progression via control of cyclin D1 expression. Oncogene 2012;32: 641-650, e-published.
14. Song LB, Li J, Liao WT, et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelialmesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009;119:3626-3636.
15. Munz M, Fellinger K, Hofmann T, et al. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. Front Biosci 2008;13:5195-5201.
16. Okamoto N, Yasukawa M, Nguyen C, et al. Maintenance of tumor initiating cells of defined genetic composition by nucleostemin. Proc Natl Acad Sci USA 2011;108:20388-20393.
17. To K, Fotovati A, Reipas KM, et al. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res 2010;70: 2840-2851.
18. Felthaus O, Ettl T, Gosau M, et al. Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Biochem Biophys Res Commun 2011;407:28-33.
19. Smith KS, Chanda SK, Lingbeek M, et al. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol Cell 2003;12:393-400.
20. Nishino J, Kim I, Chada K, et al. Hmga2 promotes neural stem cell selfrenewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 2008;135:227-239.
21. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 2007;21:525-530.
22. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;423:302-305.
23. Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ ARF. Genes Dev 1999;13:2678-2690.
24. Tanaka T, Komai Y, Tokuyama Y, et al. Identification of stem cell that maintain and regenerate lingual keratinized epithelial cells. Nat Cell Biol 2013511-518.
25. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007;7:899-910.
26. Pardal R, Molofsky AV, He S, et al. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb Symp Quant Biol 2005;70:177-185.
27. Chiba T, Miyagi S, Saraya A, et al. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 2008;68:7742-7749.
28. Meyer B, Loeschke S, Schultze A, et al. HMGA2 overexpression in nonsmall cell lung cancer. Mol Carcinog 2007;46:503-511.
29. Hetland TE, Holth A, Kaern J, et al. HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases. Virchows Arch 2012;460:505-513.
30. Hristov AC, Cope L, Reyes MD, et al. HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 2009;22:43-49.
31. Miyazawa J, Mitoro A, Kawashiri S, et al. Expression of mesenchymespecific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 2004;64:2024-2029.
32. Jang YY, Sharkis SJ. Fetal to adult stem cell transition: knocking Sox17 off. Cell 2007;130:403-404.